NCT02819115View on ClinicalTrials.gov

Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine

CompletedOBSERVATIONAL
Enrollment

63

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Influenza
Interventions
BIOLOGICAL

Butantan Fragmented Inactivated Trivalent Influenza Vaccine

Butantan Fragmented Inactivated Trivalent Influenza Vaccine

Trial Locations (2)

Unknown

Centro de Pesquisas Clínicas do Instituto da Criança do Hospital das Clínicas, São Paulo

Centro de Referência de Imunobiológicos Especiais (CRIE) Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo

Sponsors

Lead Sponsor

Butantan Institute
All Listed Sponsors
lead

Butantan Institute

OTHER_GOV